# Melinta Therapeutics, LLC

Canonical: https://abierto.us/vendors/melinta-therapeutics-llc-h8k6f2a4kd49

- UEI: H8K6F2A4KD49
- CAGE: 7XFT1
- Location: Parsippany, NJ
- Awards in window: 5 (29 transactions), $26,998,491 obligated, February 1, 2024 to July 9, 2026

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, $26,998,491
- Department of Veterans Affairs: 4 awards, $0

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $26,998,491
- 325412 Pharmaceutical Preparation Manufacturing: $0

## Competition

- Full and Open Competition: 5 awards

## Solicitations won

- Melinta Therapeutics, LLC Effective: 09-01-2024 to 08-31-2029 (36F79724D0178), $9,658,300. https://abierto.us/opportunities/36f79724d0178

## Largest awards

- 75A50123C00022 (definitive contract): $26,998,491, Barda - Aspr / Daappo / Barda DCMA. Advance the Development of Two Antibiotics for Use in the Pediatric Population for the Treatment of Serious Bacterial Infections Where Multidrug-Resistant Organisms Are Common, and 2) Develop Antibiotics for Use in Public Health and Biothreat Emergen. https://www.usaspending.gov/award/CONT_AWD_75A50123C00022_7505_-NONE-_-NONE-/
- 36E79724A0014: $0, Nac Pharmaceuticals. BPA for Rezzayo. https://www.usaspending.gov/award/CONT_IDV_36E79724A0014_3600/
- 36E79724A0033: $0, Nac Pharmaceuticals. BPA for Rezzayo. https://www.usaspending.gov/award/CONT_IDV_36E79724A0033_3600/
- 36F79718D0456: $0, Nac Federal Supply Schedule. Temporary Price Reduction. https://www.usaspending.gov/award/CONT_IDV_36F79718D0456_3600/
- 36F79724D0178: $0, Nac Federal Supply Schedule. 65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, FSS Contract Award. https://www.usaspending.gov/award/CONT_IDV_36F79724D0178_3600/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/melinta-therapeutics-llc-h8k6f2a4kd49.